Medipower Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-10-2024
- Paid Up Capital ₹ 0.50 M
as on 27-10-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 27-10-2024
About Medipower Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Anil Gupta and Priti Kumari serve as directors at the Company.
- CIN/LLPIN
U51397HR2020PTC087474
- Company No.
087474
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medipower Pharmaceuticals Private Limited offer?
Medipower Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Cardiovascular Drugs & Medication, Cholesterol Medicine, Nutraceuticals & Dietary Supplements, Mineral Supplement, Common Disease Medicines, Allopathic Cough Syrup, Arthritic Drugs, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Medipower Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gupta  | Director | 14-Jul-2020 | Current |
| Priti Kumari | Director | 21-Sep-2021 | Current |
Financial Performance of Medipower Pharmaceuticals.
Medipower Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medipower Pharmaceuticals?
Unlock access to Medipower Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Williams Pharma Private LimitedActive 2 years 7 monthsAnil Gupta and Priti Kumari are mutual person
- Addom Pharmaceuticals Private LimitedActive 7 years 3 months
Anil Gupta and Priti Kumari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Sep 2022 | ₹3.00 M | Open |
How Many Employees Work at Medipower Pharmaceuticals?
Medipower Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medipower Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medipower Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
